RCUS R&D to Revenue
Arcus Biosciences Inc · R&D to Revenue
RCUS R&D to Revenue
Latest reported275.61%period ending
RCUS Quarterly R&D/Revenue (0.00% → 275.61%)
Latest values, visible window
High-resolution chart · PNG
RCUS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 275.6098% | |
| 717.6471% | |
| 366.6667% | |
| 542.3077% | |
| 86.875% | |
| 435.7143% | |
| 388.4615% | |
| 256.25% | |
| 294.8718% | |
| 75.1724% | |
| 300% | |
| 256.25% | |
| 289.6552% | |
| 324% | |
| 238.3004% | |
| 233.3333% | |
| 259.2593% | |
| 338.8889% | |
| 14.0864% | |
| 753.1339% | |
| 726.8893% | |
| 701.6912% | |
| 513.4605% | |
| 80.2743% | |
| 2,039.6% | |
| 1,322.4% | |
| 212.1641% | |
| 985.2% | |
| 1,428.5143% | |
| 888.8% | |
| 732.1383% | |
| 299.6737% | |
| 1,095.92% | |
| 932.16% | |
| 971.68% | |
| 13,150.3067% | |
| 0% | |
| 0% |